QTC-4-MeOBnE Rescues Scopolamine-Induced Memory Deficits in Mice by Targeting Oxidative Stress, Neuronal Plasticity, and Apoptosis
- 31 March 2020
- journal article
- research article
- Published by American Chemical Society (ACS) in ACS Chemical Neuroscience
- Vol. 11 (9) , 1259-1269
Abstract
Cognitive decline and memory impairment induced by disruption of cholinergic neurons and oxidative brain damage are among the earliest pathological hallmark signatures of Alzheimer's disease. Scopolamine is a post-synaptic muscarinic receptor blocker which causes impairment of cholinergic transmission resulting in cognitive deficits. Herein we investigated the effect of QTC-4-MeOBnE (1-(7-chloroquinolin-4-yl)-N-(4-methoxybenzyl)-5-methyl-1H-1,2,3-triazole-4-carboxamide) on memory impairments in mice chronically treated with scopolamine and the molecular mechanisms involved. Administration of scopolamine (1mg/kg) for 15 days resulted in significant impairments in working and short-term memory in mice, as assessed by the novel object recognition and the Y-maze paradigms. However, both deficits were prevented if mice receiving the scopolamine were also treated with QTC-4-MeOBnE. This effect was associated with an increase in antioxidant enzymes (superoxide dismutase and catalase), a reduction in lipid peroxidation, and an increase in Nrf2 expression. Moreover, brains from QTC-4-MeOBnE treated mice had significant decrease in acetylcholinesterase activity and glycogen synthase kinase-3β levels, but an increase in brain-derived neurotrophic factor and Bcl-2 expression levels. Taken together our findings demonstrate that the beneficial effect of QTC-4-MeOBnE in a mouse model of scopolamine-induced memory impairment is mediated via the involvement of different molecular pathways including: oxidative stress, neuroplasticity, neuronal vulnerability and apoptosis. Our study provides further evidence on the promising therapeutic potential of QTC-4-MeOBnE as a multifactorial disease modifying drug in AD and related dementing disorders.Keywords
Funding Information
- Conselho Nacional de Desenvolvimento Cient?fico e Tecnol?gico
- Funda??o de Amparo ? Pesquisa do Estado do Rio Grande do Sul (04/2018 - DOCFIX 18/2551-0000511-8, 16/2551-0000240-1, 17/2551-00011046-9)
- Coordena??o de Aperfei?oamento de Pessoal de N?vel Superior (001, 04/2018 - DOCFIX 18/2551-0000511-8)
This publication has 69 references indexed in Scilit:
- Acetylcholinesterase Involvement in ApoptosisFrontiers in Molecular Neuroscience, 2012
- Cholinergic influences on cortical development and adult neurogenesisBehavioural Brain Research, 2011
- Anti-apoptosis and cell survival: A reviewBiochimica et Biophysica Acta (BBA) - Molecular Cell Research, 2011
- Oxidative Stress in the Progression of Alzheimer Disease in the Frontal CortexJournal of Neuropathology & Experimental Neurology, 2010
- Pro-apoptotic protein–protein interactions of the extended N-AChE terminusJournal of Neural Transmission, 2009
- Increased level of active GSK‐3β in Alzheimer’s disease and accumulation in argyrophilic grains and in neurones at different stages of neurofibrillary degenerationNeuropathology and Applied Neurobiology, 2007
- Glycogen Synthase Kinase-3β Phosphorylates Bax and Promotes Its Mitochondrial Localization during Neuronal ApoptosisJournal of Neuroscience, 2004
- Positive Feedback between Acetylcholine and the Neurotrophins Nerve Growth Factor and Brain‐derived Neurotrophic Factor in the Rat HippocampusEuropean Journal of Neuroscience, 1994
- A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye bindingAnalytical Biochemistry, 1976
- The open-field test: A critical review.Psychological Bulletin, 1976